Skip to main content Accessibility help
×
Home

Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy

  • M. S. DRYDEN (a1) (a2), K. SAEED (a1), S. OGBORN (a3) and P. SWALES (a3)

Summary

This series of serologically confirmed Lyme disease is the largest reported in the UK and represents 508 patients who presented to one hospital in the South of England between 1992 and 2012. The mean rate of borreliosis throughout this period was 9·8/100 000 population, much higher than the reported national rate of 1·7/100 000. The actual rate increased each year until 2009 when it levelled off. Patients clinically presented with rash (71%), neurological symptoms (16%, of whom half had VII cranial nerve palsies), arthropathy (8%), pyrexia (5%), cardiac abnormalities (1%) or other manifestations (<1%). Twenty percent of patients had additional non-specific symptoms of fatigue, myalgia, and cognitive changes. Serological diagnosis was with a two-tiered system of ELISA and immunoblot. There was a marked seasonal presentation in the summer months and in the first and sixth decades of life. A third of patients gave a clear history of a tick bite. The median interval between tick bite and clinical symptoms was 15 days [interquartile range (IQR) 9–28 days], with a further interval of 14 days to clinical diagnosis/treatment (IQR 2–31 days). Most cases were acquired locally and only 5% abroad. Patients responded to standard antibiotic therapy and recurrence or persistence was extremely rare. A second group of patients, not included in the clinical case series, were those who believed they had Lyme disease based on a probable tick bite but were seronegative by currently available validated tests and presented with subjective symptoms. This condition is often labelled chronic Lyme disease. These patients have a different disease from Lyme disease and therefore an alternative name, chronic arthropod-borne neuropathy (CAN), and case definition for this condition is proposed. We suggest that this chronic condition needs to be distinguished from Lyme disease, as calling the chronic illness ‘Lyme disease’ causes confusion to patients and physicians. We recommend research initiatives to investigate the aetiology, diagnosis and therapy of CAN.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy
      Available formats
      ×

Copyright

Corresponding author

* Author for correspondence: Dr M. S. Dryden, Department of Microbiology, Royal Hampshire County Hospital, Winchester SO22 5DG, UK. (Email: matthew.dryden@hhft.nhs.uk)

References

Hide All
1. Health Protection Agency. Epidemiology of Lyme borreliosis in the UK. March 2012. (http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/LymeDisease/). Accessed November 2013
2. British Infection Association. The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association. Journal of Infection 2011; 62: 329338.
3. Smith, R, O'Connell, S, Palmer, S. Lyme disease surveillance in England and Wales, 198 61 998. Emerging Infectious Diseases 2000; 6: 404407.
4. Mygland, A, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. European Journal of Neurology 2010; 17: 816.
5. Stanek, G, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clinical Microbiology and Infection 2011; 17: 6979.
6. O'Connell, S. Lyme borreliosis: current issues in diagnosis and management. Current Opinion in Infectious Diseases 2010; 23: 231235.
7. Dillon, R, O'Connell, S, Wright, S. Lyme disease in the UK: clinical and laboratory features and response to treatment. Clinical Medicine 2010; 10: 454457.
8. Wormser, GP, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2006; 43: 1089–134.
9. Dehnert, M, et al. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in children and adolescents in Germany (KiGGS). PLoS ONE 2012; 7: e 41 321.
10. Duncan, CJA, Carle, G, Seaton, RA. Tick bite and early Lyme borreliosis. British Medical Journal 2012; 344: e3124.
11. Wilske, B. Diagnosis of lyme borreliosis in Europe. Vector Borne Zoonotic Disease 2003, 3: 215227.
12. Lyme Disease Action. (http://www.lymediseaseaction.org.uk/).
13. Lyme Disease Association (http://www.lymediseaseassociation.org/).
14. International Lyme and Associated Diseases Society. (http://www.ilads.org/).
15. Masters, EJ, et al. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infectious Disease Clinics of North America 2008; 22: 361376.
16. Due, C, et al. Tick bite prevention and removal. British Medical Journal 2013; 347: f7123.
17. Cottle, LE, et al. Lyme disease in a British referral clinic. Quarterly Journal of Medicine 2012; 105: 537543.
18. White, B, Seaton, RA, Evans, TJ. Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service. Quarterly Journal of Medicine 2013; 106: 133138.
20. Dobson, ADM, et al. Tick (Ixodes ricinus) abundance and seasonality at recreational sites in the UK. Hazards in relation to fine-scale habitat types revealed by complementary sampling methods. Ticks & Tick-borne Diseases 2011; 2: 6774.
21. Smith, R, Takkinen, J, Editorial team. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Eurosurveillance 2006; 11: pii=2977.
22. Burrascano, J. (http://www.lymenet.org/BurrGuide200810.pdf), 2008.
23. Centers for Disease Control and Prevention. Confirmed Lyme disease cases by age and sex – United States, 2001–2010 (www.cdc.gov/lyme/stats).
24. Strle, F, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York state and Borrelia afzelii in Slovenia. Annals of Internal Medicine 1999; 130: 3236.
25. Baranton, G, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp.nov., and group VS461 associated with Lyme borreliosis. International Journal of Systematic Bacteriology 1992; 42: 378383.
26. Kruger, H, et al. Meningoradiculitis and encphalomyelitis due to Borrelia burgdorferi: a follow up study of 72 patients over 27 years. Journal of Neurology 1989; 236: 322328.
27. Hobson, J, Weatherall, MW. Lyme neuroborreliosis. British Medical Journal 2012; 344: e3250.
28. Klempner, MS, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine 2001; 345: 8592.
29. Dryden, MS, et al. Lyme myelitis mimicking neurological malignancy. Lancet 1996; 348: 642.
30. Wormser, GP, O'Connell, S. Treatment of infection caused by Borrelia burgdorferi sensu lato. Expert Review Anti Infective Therapy 2011; 9: 245260.
31. Auwaerter, PG, et al. Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infectious Diseases 2012; 11: 713719.
32. Pearson, S, Huyshe-Shires, S. Lyme borreliosis: the need for more research. Quarterly Journal of Medicine 2013; 106: 203.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed